restor3d develops personalized orthopedic implants and surgical planning tools by combining proprietary AI-driven design software with vertically integrated additive manufacturing and rapid surgical planning. The company offers FDA-cleared solutions across shoulder, hip, knee, foot, and ankle and emphasizes implants tailored to surgeon preference and patient anatomy. Founded in 2017 and led by Kurt Jacobus, restor3d reported partnering with more than 520 surgeons across 740 hospitals nationwide in 2024. The business plans to use new capital to accelerate product innovation, expand commercial growth, and broaden access to personalized orthopedic care. The company positions its vertically integrated manufacturing and software stack as a core competitive advantage for scaling patient-specific implants and surgeon workflows. No revenue or valuation figures are disclosed in the article. restor3d designs and manufactures 3D-printed, patient-specific musculoskeletal implants and provides AI-based planning and digital health solutions. The company holds proprietary expertise in 3D printing of osseointegrative materials and TIDAL Technology to promote bone integration and improve surgical precision. restor3d plans to launch four fully 3D-printed product lines in 2025 and 2026: Veritas Reverse Total Shoulder (pending FDA 510(k)), iTotal Identity 3DP Porous Cementless Total Knee (FDA 510(k) cleared last week), Kinos Modular Stem Total Ankle System (FDA 510(k) cleared late last year), and Velora 3DP Porous Acetabular System (pending FDA 510(k)). The company says the new product lines and its AI-driven design tools will enhance procedural efficiency and broaden access to personalized implants. restor3d reports it has expanded market share, driven strong year-over-year growth, and is rapidly approaching positive operating cash flow. The company is deploying its technology and commercial efforts to scale adoption of personalized orthopedic solutions. restor3d develops 3D-printed, patient-specific musculoskeletal implants and holds proprietary expertise in osseointegrative materials, AI-based planning, and digital health solutions. The company plans to introduce patient-specific implant systems for total ankle and shoulder replacements and continue product advancements in its hip and knee portfolios, including a porous press-fit knee enabled by 3D printing of both tibial and femoral components. restor3d is investing in advanced 3D printing technologies to expand its rapid in-house 'powder to sterile product' production environment, shorten delivery times, and reduce production costs. It is also investing in software and AI-based design automation to speed case intake and design processes and improve service levels to surgeons. The company will expand medical education and training programs for surgeons and its sales team to support adoption of new technologies and surgical techniques. restor3d emphasizes personalized care and digital, data-backed solutions to optimize individual patient outcomes. restor3d develops 3D-printed, patient-specific implants and disposable instruments to improve reconstruction and repair across musculoskeletal specialties. The company leverages advanced biomedical materials, anatomic and kinematic modeling, and AI-based planning and design tools. restor3d holds multiple FDA clearances spanning lower extremity, upper extremity, spine, and trauma. Recent corporate activity includes a 2021 merger with Kinos Medical, accelerating expansion into extremity arthroplasty markets. Planned uses of new capital include new product introductions, development of machine-learning enabled software for surgical planning and implant design, and expanded preclinical and clinical research. restor3d is based in Durham, North Carolina, and plans to move into a larger Research Triangle Park facility to expand in-house manufacturing and surgeon training.

Total raised

$235M

Funding rounds

5

Latest round

Equity

Latest activity

Aug 2025